Artificial intelligence in type 1 diabetes management: a scoping review of randomised controlled trials
Wu Y, Pang J, Xu S, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
Dementia risk in type 1 and 2 diabetes: a nationwide population‐based comparison
Jun JE, Kim S, Jeong IK, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer’s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
Cummings JL, Atri A, Sano M, et al.
Lancet. Pub. online 19 Mar 2026.
Leggi
American Association of Clinical Endocrinology consensus statement: algorithm for management of adults with type 2 diabetes – 2026 update
Samson SL, Vellanki P, Blonde L, et al.
Endocr Pract. Pub. online 17 Mar 2026.
Leggi
A type 2 diabetes policy model that predicts remaining life expectancy, quality-adjusted life expectancy and healthcare costs for use in economic evaluation, incorporating equity concerns
Wei L, Haghpanahan H, Wild SH, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
Data-driven phenotypic clusters of gestational diabetes mellitus and associations with risk of perinatal complications and postpartum diabetes
Zhu Y, Ngo AL, Liao LD, et al.
Diabetes Care. Pub. online 17 Mar 2026.
Leggi
Highly uncontrolled cardiovascular risk in emerging adults with paediatric-onset type 1 diabetes-a cross-sectional analysis from the diabetes prospective follow-up registry DPV
Welters A, Reinauer C, Schwab KO, et al.
Diabetes Obes Metab. Pub. online 16 Mar 2026.
Leggi
Shrunken pore syndrome and risk of cardiovascular disease and all-cause mortality in individuals with type 1 diabetes with and without albuminuria
Harjutsalo V, Thorn LM, Sandholm N, Groop PH; FinnDiane Study Group
Diabetes Care. Pub. online 17 Mar 2026.
Leggi
Association between type 2 diabetes and site-specific fracture risk: a systematic review and meta-analysis of cohort studies including over 13 million participants
Naderpour S, Gillies C, O’Riordan P, et al.
Diabet Med. Pub. online 13 Mar 2026.
Leggi
Obesity treatments and weight changes in clinical practice after discontinuation of semaglutide or tirzepatide
Gasoyan H, Schulte R, Boyer CB, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi